Bibliographic information
GuidelineWHO guidelines for malaria, 3 June 2022.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Maintained
Treat pregnant women in their first trimester who have chloroquine-resistant P. vivax malaria with quinine.
Recommended in favor
Strong
Certainty of evidence
Very low
Notes and Remarks
Practical Info Please refer to Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale (Policy brief) [203] and Guide to G6PD deficiency rapid diagnostic testing to support P. vivax radical cure [172].
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for the treatment of malaria
Year2015
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 16 February 2021.
Year2021
InstitutionWHO
Guideline
WHO guidelines for malaria, 13 July 2021.
Year2021
InstitutionWHO
Guideline
WHO guidelines for malaria, 18 February 2022.
Year2022
InstitutionWHO
Guideline
WHO guidelines for malaria, 31 March 2022.
Year2022
InstitutionWHO
Guideline
WHO Guidelines for malaria, 14 March 2023
Year2023
InstitutionWHO